CONMED Corporation (CNMD)
NYSE: CNMD · IEX Real-Time Price · USD
67.04
+0.05 (0.07%)
Jul 2, 2024, 4:00 PM EDT - Market closed
CONMED Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CONMED stock have an average target of 101.86, with a low estimate of 75 and a high estimate of 141. The average target predicts an increase of 51.94% from the current stock price of 67.04.
Analyst Consensus: Buy
* Price targets were last updated on May 6, 2024.
Analyst Ratings
The average analyst rating for CONMED stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $107 | Strong Buy | Reiterates | $107 | +59.61% | May 6, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $115 → $75 | Buy | Maintains | $115 → $75 | +11.87% | Apr 25, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $98 → $77 | Hold | Maintains | $98 → $77 | +14.86% | Apr 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $95 | Buy | Maintains | $100 → $95 | +41.71% | Apr 25, 2024 |
| Needham | Needham | Strong Buy Maintains $129 → $107 | Strong Buy | Maintains | $129 → $107 | +59.61% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
1.36B
from 1.24B
Increased by 8.86%
Revenue Next Year
1.47B
from 1.36B
Increased by 8.12%
EPS This Year
4.38
from 2.04
Increased by 114.64%
EPS Next Year
5.61
from 4.38
Increased by 28.03%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.4B | 1.5B | 1.7B | 1.8B |
| Avg | 1.4B | 1.5B | 1.6B | 1.7B |
| Low | 1.2B | 1.3B | 1.4B | 1.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 13.5% | 13.7% | 13.4% | 12.6% |
| Avg | 8.9% | 8.1% | 7.0% | 8.4% |
| Low | -2.0% | -2.8% | -2.4% | 3.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.52 | 6.02 | 6.92 | 7.85 |
| Avg | 4.38 | 5.61 | 6.56 | 7.63 |
| Low | 4.17 | 5.17 | 6.09 | 7.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 121.3% | 37.4% | 23.4% | 19.7% |
| Avg | 114.6% | 28.0% | 17.0% | 16.3% |
| Low | 104.5% | 18.2% | 8.6% | 11.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.